Heparin management by activated coagulation time during cardiopulmonary bypass
Shikano, K.; Shinpo, H.; Nasu, M.; Morimoto, T.; Suzuki, T.; Yada, I.; Kusagawa, M.
Kyobu Geka. Japanese Journal of Thoracic Surgery 34(12): 934-937
1981
ISSN/ISBN: 0021-5252 PMID: 7349352 Document Number: 179919
Document emailed within 1 workday
Related Documents
Xu, L.; He, Z.; Shen, J. 1998: Effects of aprotinin on activated coagulation time in the patients during cardiopulmonary bypass Hunan Yi Ke da Xue Xue Bao 23(2): 215-216Akl, B.F.; Vargas, G.M.; Neal, J.; Robillard, J.; Kelly, P. 1980: Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 79(1): 97-102
Kanno, M.; Edanaga, M.; Mizukami, N.; Tokinaga, Y.; Niiyama, Y.; Yamakage, M. 2015: Successful Management of Cardiopulmonary Bypass Using Heparin in a Patient with Previous History of Heparin-induced Thrombocytopenia Masui. Japanese Journal of Anesthesiology 64(4): 449-452
Sawai, T.; Uchida, O.; Inamori, S.; Kuro, M. 2003: Successful management after cardiopulmonary bypass without administration of protamine in a patient with severe food allergy--beneficial result with the use of heparin-coated bypass circuit Masui. Japanese Journal of Anesthesiology 52(3): 280-283
Linden, M.D.; Erber, W.N.; Schneider, M. 2001: Heparin management during cardiopulmonary bypass Journal of Cardiovascular Surgery 42(3): 431-433
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Suehiro, S.; Shibata, T.; Sasaki, Y.; Hattori, K.; Kumano, H.; Hosono, M.; Kinoshita, H. 1999: Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 5(4): 225-229
Isomatsu, Y.; Imai, Y.; Seo, K.; Terada, M.; Aoki, M.; Shin'oka, T. 2000: Heparin monitoring during cardiopulmonary bypass in congenital heart surgery Kyobu Geka. Japanese Journal of Thoracic Surgery 53(12): 1001-1004
Arén, C.; Feddersen, K.; Rådegran, K. 1987: Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 94(4): 539-541
Sakamoto, T.; Asou, T.; Takeda, Y.; Date, K.; Nanaumi, M.; Nagafuchi, H.; Koga, N.; Ohmiya, A.; Chiba, S. 2006: Coagulation and fibrinolysis system in pediatric cardiopulmonary bypass Kyobu Geka. Japanese Journal of Thoracic Surgery 59(13): 1163-1170
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Paparella, D.; Micelli, M.; Favoino, B.; D'Alò, M.; Fiore, T.; de Luca Tupputi Schinosa, L. 2001: Anti-heparin-platelet factor 4 antibodies after cardiopulmonary bypass: role of HLA expression Haematologica 86(3): 326-327
Gotou, K.; Kimura, F.; Kimura, N.; Hashimoto, Y.; Wakayama, S. 1997: The anesthetic management of patients in chronic renal failure for coronary artery bypass surgery without cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 46(12): 1609-1614
Tamim, M.; Demircin, M.; Guvener, M.; Peker, O.; Yilmaz, M. 1999: Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass Panminerva Medica 41(3): 193-198
Umlas, J.; Sakhuja, R. 1975: The effect on blood coagulation of the exclusive use of transfusions of frozen red cells during and after cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 70(3): 519-523
Shah, A.C.; Genoni, M.; Niederhäuser, U.; Maloigne, M.; Turina, M. 2000: R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection Schweizerische Medizinische Wochenschrift 130(23): 896-899
Yuan, S-Min. 2015: Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy Pakistan journal of pharmaceutical sciences 28(5): 1793-1796
Schiffer, S.P.; Gillett, C.S.; Ringler, D.H. 1984: Activated coagulation time for rhesus monkeys (Macaca mulatta) Laboratory Animal Science 34(2): 191-193
Uszyński, L.; Klukowski, M. 1984: Monitoring heparin therapy by the determination of blood coagulation time using kaolin Polski Tygodnik Lekarski 39(46): 1505-1507
Daudt, C.A.; Pereira, S.N.; Moraes, L.B.; Costa, P.S.; Deboni, L.M.; Figueiredo, M.S. 1989: Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation Arquivos Brasileiros de Cardiologia 52(3): 137-139